Table 4

Evolution of the HFMS scores in the two age groups of SMA patients during the VPA treatment.

Evaluations


Age

1

2

3

4

5

p (*)


≤ 6 years

21.5 ± 8.8

22.5 ± 9.5

22.9 ± 8.7

23.2 ± 8.3

23.5 ± 8.7

0.240

> 6 years

12.2 ± 8.8

12.7 ± 9.0

12.8 ± 9.0

13.0 ± 9.2

12.8 ± 9.1

0.922

p (**)

0.018

0.012

0.010

0.009

0.007


* Comparison between the first evaluation with the subsequent ones

** Comparison between both groups of patients in each evaluation

Darbar et al. BMC Neurology 2011 11:36   doi:10.1186/1471-2377-11-36

Open Data